Comparative Study of Safety and Efficacy of Two Hyaluronic Acids for the Treatment of Knee Osteoarthritis Pain

NCT01295580 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 349

Last updated 2021-04-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the comparative safety and efficacy of intra-articular injection of hyaluronic acid, obtained from two different sources, in the treatment of osteoarthritic pain of the knee.

Conditions

Interventions

DEVICE

ARTZ

Hyaluronic acid (five 2.5 mL injections)

DEVICE

DUROLANE

Hyaluronic acid stabilized (one 3.0 mL injection + four weekly 0 mL sham injections)

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    collaborator INDUSTRY
  • Bioventus LLC

    lead INDUSTRY

Principal Investigators

  • Jianhao Lin, MD · People Hospital of Beijing University No. 11 South Ave., Xizhimen, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-08-31
Completion
2012-02-29

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01295580 on ClinicalTrials.gov